American Cancer Society lung cancer screening guidelines

Richard Wender, Elizabeth T.H. Fontham, Ermilo Barrera, Graham A. Colditz, Timothy R. Church, David S. Ettinger, Ruth Etzioni, Christopher R. Flowers, G. Scott Gazelle, Douglas K. Kelsey, Samuel J. Lamonte, James S. Michaelson, Kevin C. Oeffinger, Ya Chen Tina Shih, Daniel C. Sullivan, William Travis, Louise Walter, Andrew M.D. Wolf, Otis W. Brawley, Robert A. Smith

Research output: Contribution to journalArticle

397 Citations (Scopus)

Abstract

Answer questions and earn CME/CNE Findings from the National Cancer Institute's National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation.

Original languageEnglish (US)
Pages (from-to)106-117
Number of pages12
JournalCA Cancer Journal for Clinicians
Volume63
Issue number2
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Early Detection of Cancer
Lung Neoplasms
Guidelines
Smoking Cessation
Tomography
Lung
National Cancer Institute (U.S.)
Smoke
Counseling
Decision Making
Smoking
History
Mortality

Keywords

  • adverse effects
  • computed tomography
  • humans
  • lung cancer screening
  • lung neoplasms
  • mortality
  • radiation dosage
  • radiography
  • randomized controlled trials as topic
  • risk
  • risk reduction behavior
  • x-ray

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Wender, R., Fontham, E. T. H., Barrera, E., Colditz, G. A., Church, T. R., Ettinger, D. S., ... Smith, R. A. (2013). American Cancer Society lung cancer screening guidelines. CA Cancer Journal for Clinicians, 63(2), 106-117. https://doi.org/10.3322/caac.21172

American Cancer Society lung cancer screening guidelines. / Wender, Richard; Fontham, Elizabeth T.H.; Barrera, Ermilo; Colditz, Graham A.; Church, Timothy R.; Ettinger, David S.; Etzioni, Ruth; Flowers, Christopher R.; Scott Gazelle, G.; Kelsey, Douglas K.; Lamonte, Samuel J.; Michaelson, James S.; Oeffinger, Kevin C.; Shih, Ya Chen Tina; Sullivan, Daniel C.; Travis, William; Walter, Louise; Wolf, Andrew M.D.; Brawley, Otis W.; Smith, Robert A.

In: CA Cancer Journal for Clinicians, Vol. 63, No. 2, 01.01.2013, p. 106-117.

Research output: Contribution to journalArticle

Wender, R, Fontham, ETH, Barrera, E, Colditz, GA, Church, TR, Ettinger, DS, Etzioni, R, Flowers, CR, Scott Gazelle, G, Kelsey, DK, Lamonte, SJ, Michaelson, JS, Oeffinger, KC, Shih, YCT, Sullivan, DC, Travis, W, Walter, L, Wolf, AMD, Brawley, OW & Smith, RA 2013, 'American Cancer Society lung cancer screening guidelines', CA Cancer Journal for Clinicians, vol. 63, no. 2, pp. 106-117. https://doi.org/10.3322/caac.21172
Wender R, Fontham ETH, Barrera E, Colditz GA, Church TR, Ettinger DS et al. American Cancer Society lung cancer screening guidelines. CA Cancer Journal for Clinicians. 2013 Jan 1;63(2):106-117. https://doi.org/10.3322/caac.21172
Wender, Richard ; Fontham, Elizabeth T.H. ; Barrera, Ermilo ; Colditz, Graham A. ; Church, Timothy R. ; Ettinger, David S. ; Etzioni, Ruth ; Flowers, Christopher R. ; Scott Gazelle, G. ; Kelsey, Douglas K. ; Lamonte, Samuel J. ; Michaelson, James S. ; Oeffinger, Kevin C. ; Shih, Ya Chen Tina ; Sullivan, Daniel C. ; Travis, William ; Walter, Louise ; Wolf, Andrew M.D. ; Brawley, Otis W. ; Smith, Robert A. / American Cancer Society lung cancer screening guidelines. In: CA Cancer Journal for Clinicians. 2013 ; Vol. 63, No. 2. pp. 106-117.
@article{a3f9521f728640d49e966392bde531c5,
title = "American Cancer Society lung cancer screening guidelines",
abstract = "Answer questions and earn CME/CNE Findings from the National Cancer Institute's National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation.",
keywords = "adverse effects, computed tomography, humans, lung cancer screening, lung neoplasms, mortality, radiation dosage, radiography, randomized controlled trials as topic, risk, risk reduction behavior, x-ray",
author = "Richard Wender and Fontham, {Elizabeth T.H.} and Ermilo Barrera and Colditz, {Graham A.} and Church, {Timothy R.} and Ettinger, {David S.} and Ruth Etzioni and Flowers, {Christopher R.} and {Scott Gazelle}, G. and Kelsey, {Douglas K.} and Lamonte, {Samuel J.} and Michaelson, {James S.} and Oeffinger, {Kevin C.} and Shih, {Ya Chen Tina} and Sullivan, {Daniel C.} and William Travis and Louise Walter and Wolf, {Andrew M.D.} and Brawley, {Otis W.} and Smith, {Robert A.}",
year = "2013",
month = "1",
day = "1",
doi = "10.3322/caac.21172",
language = "English (US)",
volume = "63",
pages = "106--117",
journal = "CA Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - American Cancer Society lung cancer screening guidelines

AU - Wender, Richard

AU - Fontham, Elizabeth T.H.

AU - Barrera, Ermilo

AU - Colditz, Graham A.

AU - Church, Timothy R.

AU - Ettinger, David S.

AU - Etzioni, Ruth

AU - Flowers, Christopher R.

AU - Scott Gazelle, G.

AU - Kelsey, Douglas K.

AU - Lamonte, Samuel J.

AU - Michaelson, James S.

AU - Oeffinger, Kevin C.

AU - Shih, Ya Chen Tina

AU - Sullivan, Daniel C.

AU - Travis, William

AU - Walter, Louise

AU - Wolf, Andrew M.D.

AU - Brawley, Otis W.

AU - Smith, Robert A.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Answer questions and earn CME/CNE Findings from the National Cancer Institute's National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation.

AB - Answer questions and earn CME/CNE Findings from the National Cancer Institute's National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation.

KW - adverse effects

KW - computed tomography

KW - humans

KW - lung cancer screening

KW - lung neoplasms

KW - mortality

KW - radiation dosage

KW - radiography

KW - randomized controlled trials as topic

KW - risk

KW - risk reduction behavior

KW - x-ray

UR - http://www.scopus.com/inward/record.url?scp=84874688661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874688661&partnerID=8YFLogxK

U2 - 10.3322/caac.21172

DO - 10.3322/caac.21172

M3 - Article

VL - 63

SP - 106

EP - 117

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

SN - 0007-9235

IS - 2

ER -